Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS)
CNY 4.5
(-0.66%)
CNY 4.5
(-0.66%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 169.4 Million CNY | -13.37% |
| 2022 | 185.66 Million CNY | -25.15% |
| 2021 | 248.05 Million CNY | 25.48% |
| 2020 | 197.68 Million CNY | -42.01% |
| 2019 | 340.89 Million CNY | 46.52% |
| 2018 | 232.66 Million CNY | 23.64% |
| 2017 | 188.17 Million CNY | 185.26% |
| 2016 | 65.96 Million CNY | -21.35% |
| 2015 | 83.87 Million CNY | 20.09% |
| 2014 | 69.84 Million CNY | 56.32% |
| 2013 | 44.67 Million CNY | -58.98% |
| 2012 | 108.91 Million CNY | 8.59% |
| 2011 | 100.3 Million CNY | -0.89% |
| 2010 | 101.2 Million CNY | 38.59% |
| 2009 | 73.02 Million CNY | 32.33% |
| 2008 | 55.18 Million CNY | 77.69% |
| 2007 | 31.05 Million CNY | -41.14% |
| 2006 | 52.76 Million CNY | -44.59% |
| 2005 | 95.23 Million CNY | -21.95% |
| 2004 | 122.01 Million CNY | 14.26% |
| 2003 | 106.78 Million CNY | -1.49% |
| 2002 | 108.4 Million CNY | 18.32% |
| 2001 | 91.62 Million CNY | 17.53% |
| 2000 | 77.95 Million CNY | 23.9% |
| 1999 | 62.92 Million CNY | 331.43% |
| 1998 | 14.58 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 114.47 Million CNY | 46.38% |
| 2024 Q1 | 78.19 Million CNY | 229.61% |
| 2024 Q3 | 60.75 Million CNY | -46.92% |
| 2023 Q2 | 75.73 Million CNY | -19.13% |
| 2023 Q4 | -60.33 Million CNY | -241.52% |
| 2023 Q1 | 93.65 Million CNY | 804.05% |
| 2023 FY | 160.84 Million CNY | -13.37% |
| 2023 Q3 | 42.63 Million CNY | -43.71% |
| 2022 Q2 | 79.88 Million CNY | 281.18% |
| 2022 Q1 | 20.95 Million CNY | -15.24% |
| 2022 FY | 185.66 Million CNY | -25.15% |
| 2022 Q4 | 10.35 Million CNY | -92.26% |
| 2022 Q3 | 133.77 Million CNY | 67.45% |
| 2021 Q3 | 20.91 Million CNY | -43.58% |
| 2021 FY | 248.05 Million CNY | 25.48% |
| 2021 Q1 | 63.11 Million CNY | 343.5% |
| 2021 Q2 | 37.07 Million CNY | -41.26% |
| 2021 Q4 | 24.72 Million CNY | 18.22% |
| 2020 Q1 | 60.37 Million CNY | 31.72% |
| 2020 FY | 197.68 Million CNY | -42.01% |
| 2020 Q3 | 26.26 Million CNY | -63.38% |
| 2020 Q4 | -25.92 Million CNY | -198.7% |
| 2020 Q2 | 71.7 Million CNY | 18.78% |
| 2019 Q1 | 59.39 Million CNY | -4.72% |
| 2019 Q4 | 45.83 Million CNY | -44.05% |
| 2019 FY | 340.89 Million CNY | 46.52% |
| 2019 Q3 | 81.91 Million CNY | 25.33% |
| 2019 Q2 | 65.36 Million CNY | 10.05% |
| 2018 Q4 | 62.33 Million CNY | 9.78% |
| 2018 FY | 232.66 Million CNY | 23.64% |
| 2018 Q2 | 68.07 Million CNY | 49.71% |
| 2018 Q1 | 45.47 Million CNY | 0.73% |
| 2018 Q3 | 56.78 Million CNY | -16.59% |
| 2017 FY | 188.17 Million CNY | 185.26% |
| 2017 Q4 | 45.14 Million CNY | 12.02% |
| 2017 Q3 | 40.29 Million CNY | -55.7% |
| 2017 Q2 | 90.96 Million CNY | 672.39% |
| 2017 Q1 | 11.77 Million CNY | 38.62% |
| 2016 FY | 65.96 Million CNY | -21.35% |
| 2016 Q4 | 8.49 Million CNY | -35.82% |
| 2016 Q3 | 13.23 Million CNY | -48.34% |
| 2016 Q2 | 25.62 Million CNY | 37.64% |
| 2016 Q1 | 18.61 Million CNY | 576.36% |
| 2015 Q2 | 37.78 Million CNY | 124.29% |
| 2015 Q4 | 2.75 Million CNY | -89.61% |
| 2015 Q1 | 16.84 Million CNY | -34.2% |
| 2015 FY | 83.87 Million CNY | 20.09% |
| 2015 Q3 | 26.48 Million CNY | -29.91% |
| 2014 FY | 69.84 Million CNY | 56.32% |
| 2014 Q3 | 27.76 Million CNY | 88.27% |
| 2014 Q1 | 1.72 Million CNY | 115.72% |
| 2014 Q2 | 14.74 Million CNY | 756.66% |
| 2014 Q4 | 25.6 Million CNY | -7.77% |
| 2013 Q2 | 8.94 Million CNY | -59.67% |
| 2013 Q1 | 22.16 Million CNY | -38.27% |
| 2013 Q4 | -10.95 Million CNY | -144.66% |
| 2013 FY | 44.67 Million CNY | -58.98% |
| 2013 Q3 | 24.52 Million CNY | 174.32% |
| 2012 FY | 108.91 Million CNY | 8.59% |
| 2012 Q2 | 24.76 Million CNY | 51.81% |
| 2012 Q4 | 35.91 Million CNY | 12.48% |
| 2012 Q3 | 31.92 Million CNY | 28.92% |
| 2012 Q1 | 16.31 Million CNY | -41.32% |
| 2011 Q4 | 27.79 Million CNY | -5.33% |
| 2011 Q2 | 23.07 Million CNY | 15.04% |
| 2011 FY | 100.3 Million CNY | -0.89% |
| 2011 Q1 | 20.06 Million CNY | -39.91% |
| 2011 Q3 | 29.36 Million CNY | 27.23% |
| 2010 Q3 | 29.76 Million CNY | 41.76% |
| 2010 FY | 101.2 Million CNY | 38.59% |
| 2010 Q1 | 17.04 Million CNY | -3.2% |
| 2010 Q4 | 33.38 Million CNY | 12.16% |
| 2010 Q2 | 20.99 Million CNY | 23.2% |
| 2009 Q1 | 11.07 Million CNY | 79.04% |
| 2009 FY | 73.02 Million CNY | 32.33% |
| 2009 Q2 | 21.23 Million CNY | 91.75% |
| 2009 Q3 | 23.1 Million CNY | 8.82% |
| 2009 Q4 | 17.6 Million CNY | -23.79% |
| 2008 Q3 | 19.11 Million CNY | -0.33% |
| 2008 Q1 | 10.7 Million CNY | 4252.2% |
| 2008 FY | 55.18 Million CNY | 77.69% |
| 2008 Q4 | 6.18 Million CNY | -67.65% |
| 2008 Q2 | 19.18 Million CNY | 79.26% |
| 2007 Q1 | 10.32 Million CNY | 267.59% |
| 2007 FY | 31.05 Million CNY | -41.14% |
| 2007 Q4 | 245.86 Thousand CNY | -97.12% |
| 2007 Q3 | 8.52 Million CNY | -28.71% |
| 2007 Q2 | 11.95 Million CNY | 15.78% |
| 2006 Q3 | 12.85 Million CNY | -36.14% |
| 2006 Q4 | 2.8 Million CNY | -78.14% |
| 2006 FY | 52.76 Million CNY | -44.59% |
| 2006 Q2 | 20.12 Million CNY | 18.53% |
| 2006 Q1 | 16.97 Million CNY | 3.93% |
| 2005 Q2 | 28.12 Million CNY | 15.57% |
| 2005 Q1 | 24.33 Million CNY | -8.24% |
| 2005 Q4 | 16.33 Million CNY | -38.21% |
| 2005 Q3 | 26.43 Million CNY | -5.99% |
| 2005 FY | 95.23 Million CNY | -21.95% |
| 2004 Q2 | 39.98 Million CNY | 26.0% |
| 2004 FY | 122.01 Million CNY | 14.26% |
| 2004 Q3 | 23.77 Million CNY | -40.55% |
| 2004 Q1 | 31.73 Million CNY | -3.45% |
| 2004 Q4 | 26.52 Million CNY | 11.55% |
| 2003 FY | 106.78 Million CNY | -1.49% |
| 2003 Q3 | 28.15 Million CNY | 23.79% |
| 2003 Q4 | 32.86 Million CNY | 16.73% |
| 2003 Q2 | 22.74 Million CNY | -1.18% |
| 2003 Q1 | 23.01 Million CNY | -2.6% |
| 2002 Q2 | 32.99 Million CNY | 20.98% |
| 2002 FY | 108.4 Million CNY | 18.32% |
| 2002 Q1 | 27.27 Million CNY | 0.0% |
| 2002 Q3 | 24.51 Million CNY | -25.7% |
| 2002 Q4 | 23.63 Million CNY | -3.6% |
| 2001 FY | 91.62 Million CNY | 17.53% |
| 2000 FY | 77.95 Million CNY | 23.9% |
| 1999 FY | 62.92 Million CNY | 331.43% |
| 1998 FY | 14.58 Million CNY | 0.0% |